OPG additionally serves as a decoy receptor for TNF related apoptosis inducing ligand (TRAIL) and may downregulate TRAIL-signaling, a process promoting cell death, especially in estrogen receptor (ER) negative breast cancer cells [6]. Here, ESR1 is linked to breast carcinoma.